Related references
Note: Only part of the references are listed.Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis
Dominique S. Genest et al.
KIDNEY INTERNATIONAL REPORTS (2022)
POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY AT 6 MONTHS
J. Barratt et al.
Kidney International Reports (2022)
Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction
Hui Wang et al.
CELL DEATH & DISEASE (2022)
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
Maxime Teisseyre et al.
FRONTIERS IN IMMUNOLOGY (2022)
Identification of Hub Genes and Immune-Related Pathways for Membranous Nephropathy by Bioinformatics Analysis
Xiao-Yu Cai et al.
FRONTIERS IN PHYSIOLOGY (2022)
The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy
Pallavi Manral et al.
FRONTIERS IN IMMUNOLOGY (2022)
The correlation of anti-β2-glycoprotein I antibody with complement activation in patients with idiopathic membranous nephropathy
Qiankun Zhang et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2021)
Clinical significance of glomerular C3 deposition in primary membranous nephropathy
Ozgur Akin Oto et al.
JOURNAL OF NEPHROLOGY (2021)
The Role of Properdin in C5 Convertase Activity and C5b-9 Formation in the Complement Alternative Pathway
Marloes A. H. M. Michels et al.
JOURNAL OF IMMUNOLOGY (2021)
Rituximab in Membranous Nephropathy
Philipp Gauckler et al.
KIDNEY INTERNATIONAL REPORTS (2021)
Establishing a Case for Anti-complement Therapy in Membranous Nephropathy
Isabelle Ayoub et al.
KIDNEY INTERNATIONAL REPORTS (2021)
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Brad H. Rovin et al.
KIDNEY INTERNATIONAL (2021)
Avacopan for the Treatment of ANCA-Associated Vasculitis
David R. W. Jayne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Association between anti-complement factor H antibodies and renal outcome in primary membranous nephropathy
Yu Kagaya et al.
CLINICAL NEPHROLOGY (2021)
Complement activation in IgA nephropathy
Nicholas R. Medjeral-Thomas et al.
SEMINARS IN IMMUNOPATHOLOGY (2021)
Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy
Elias Jatem-Escalante et al.
CLINICAL KIDNEY JOURNAL (2021)
Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy
Sanjeev Sethi et al.
KIDNEY INTERNATIONAL (2020)
A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease
Francesco Paolo Schena et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Proteomic Analysis of Complement Proteins in Membranous Nephropathy
Aishwarya Ravindran et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
Supreet Sethi et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients
Sanjeev Sethi et al.
KIDNEY INTERNATIONAL (2020)
Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies
Shane A. Bobart et al.
KIDNEY INTERNATIONAL (2019)
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases
Anna Schubart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Low serum C3 level, high neutrophil-lymphocyte-ratio, and high platelet-lymphocyte-ratio all predicted poor long-term renal survivals in biopsy-confirmed idiopathic membranous nephropathy
Shang-Feng Tsai et al.
SCIENTIFIC REPORTS (2019)
Complement activation products in the circulation and urine of primary membranous nephropathy
Mu-fan Zhang et al.
BMC NEPHROLOGY (2019)
Regulation of regulators: Role of the complement factor H-related proteins
Marcell Cserhalmi et al.
SEMINARS IN IMMUNOLOGY (2019)
Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics
Christopher J. Patriquin et al.
TRANSFUSION MEDICINE REVIEWS (2019)
Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation
Mael Lateb et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy
Norifumi Hayashi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Clinical and prognostic significance of glomerular C1q deposits in primary MN
Mu-fan Zhang et al.
CLINICA CHIMICA ACTA (2018)
Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy
Wentian Luo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Clinical implications of pathological features of primary membranous nephropathy
Xiao-dan Zhang et al.
BMC NEPHROLOGY (2018)
Factor H Autoantibodies and Membranous Nephropathy
Claudia Seikrit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Mannose-Binding Lectin2 Gene Polymorphism and IgG4 in Membranous Nephropathy
Denise Maria do Nascimento Costa et al.
NEPHRON (2018)
Complement in ANCA-associated vasculitis: mechanisms and implications for management
Min Chen et al.
NATURE REVIEWS NEPHROLOGY (2017)
IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study
Yang Yang et al.
IMMUNOLOGIC RESEARCH (2016)
A journey through the lectin pathway of complementMBL and beyond
Peter Garred et al.
IMMUNOLOGICAL REVIEWS (2016)
AJKD Atlas of Renal Pathology: Membranous Nephropathy
Agnes B. Fogo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
The Complement System in Lupus Nephritis
Daniel J. Birmingham et al.
SEMINARS IN NEPHROLOGY (2015)
Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
Nicola M. Tomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The incidence of primary glomerulonephritis worldwide: a systematic review of the literature
Anita McGrogan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Complement inhibition by human vitronectin involves non-heparin binding domains
M. SHEEHAN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Cytochrome P450 2B1 Mediates Complement-dependent Sublytic Injury in a Model of Membranous Nephropathy
Hua Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
IgG subclasses and complement pathway in segmental and global membranous nephropathy
Yoshie Segawa et al.
PEDIATRIC NEPHROLOGY (2010)
Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
Stefan Heinen et al.
BLOOD (2009)
M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy.
Laurence H. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Complement activation by tubular cells is mediated by properdin binding
Hilde Gaarkeuken et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Alternative roles for CD59
Fiona C. Kimberley et al.
MOLECULAR IMMUNOLOGY (2007)
The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells
K Abe et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy
M Endo et al.
NEPHRON CLINICAL PRACTICE (2004)
Urinary excretion of complement C3d in patients with renal diseases
AJ Branten et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy
AM Saran et al.
KIDNEY INTERNATIONAL (2003)
Complement 1 inhibitor is a regulator of the alternative complement pathway
HX Jiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Glomerular complement regulation is overwhelmed in passive Heymann nephritis
PN Cunningham et al.
KIDNEY INTERNATIONAL (2001)
Complement-induced phospholipase A2 activation in experimental membranous nephropathy
AV Cybulsky et al.
KIDNEY INTERNATIONAL (2000)
Renal C3 synthesis in idiopathic membranous nephropathy: Correlation to urinary C5b-9 excretion
V Montinaro et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
